{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:18:53Z","timestamp":1794467933270,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03157-5","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T16:56:10Z","timestamp":1774889770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["High inflammatory burden may link non-albuminuric diabetic kidney disease to carotid atherosclerosis"],"prefix":"10.1186","volume":"25","author":[{"given":"Maurizio","family":"Di Marco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Scilletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Miano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Marrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Natalicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Cignarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina Annamaria","family":"Genchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giorgino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giosiana","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Giacomo Barbagallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Scicali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Galeano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tumminia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Milluzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Frittitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Piro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Di Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"3157_CR1","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12:2032\u201345. https:\/\/doi.org\/10.2215\/CJN.11491116.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3157_CR2","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","volume":"18","author":"K Matsushita","year":"2022","unstructured":"Matsushita K, Ballew SH, Wang AY-M, Kalyesubula R, Schaeffner E, Agarwal R. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022;18:696\u2013707. https:\/\/doi.org\/10.1038\/s41581-022-00616-6.","journal-title":"Nat Rev Nephrol"},{"key":"3157_CR3","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41581-021-00462-y","volume":"17","author":"M Oshima","year":"2021","unstructured":"Oshima M, Shimizu M, Yamanouchi M, Toyama T, Hara A, Furuichi K, et al. Trajectories of kidney function in diabetes: a clinicopathological update. Nat Rev Nephrol. 2021;17:740\u201350. https:\/\/doi.org\/10.1038\/s41581-021-00462-y.","journal-title":"Nat Rev Nephrol"},{"key":"3157_CR4","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3390\/biom13050752","volume":"13","author":"S Scilletta","year":"2023","unstructured":"Scilletta S, Di Marco M, Miano N, Filippello A, Di Mauro S, Scamporrino A, et al. Update on diabetic kidney disease (DKD): focus on non-albuminuric DKD and cardiovascular risk. Biomolecules. 2023;13:752. https:\/\/doi.org\/10.3390\/biom13050752.","journal-title":"Biomolecules"},{"key":"3157_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4093\/dmj.2021.0329","volume":"46","author":"C-Y Jung","year":"2022","unstructured":"Jung C-Y, Yoo T-H. Pathophysiologic mechanisms and potential biomarkers in diabetic kidney disease. Diabetes Metab J. 2022;46:181\u201397. https:\/\/doi.org\/10.4093\/dmj.2021.0329.","journal-title":"Diabetes Metab J"},{"key":"3157_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","volume":"102","author":"KR Tuttle","year":"2022","unstructured":"Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, et al. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022;102:248\u201360. https:\/\/doi.org\/10.1016\/j.kint.2022.05.012.","journal-title":"Kidney Int"},{"key":"3157_CR7","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1053\/j.ajkd.2022.04.016","volume":"80","author":"M Epstein","year":"2022","unstructured":"Epstein M, Kovesdy CP, Clase CM, Sood MM, Pecoits-Filho R. Aldosterone, mineralocorticoid receptor activation, and CKD: A review of evolving treatment paradigms. Am J Kidney Dis. 2022;80:658\u201366. https:\/\/doi.org\/10.1053\/j.ajkd.2022.04.016.","journal-title":"Am J Kidney Dis"},{"key":"3157_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11892-021-01442-z","volume":"22","author":"CJ Bailey","year":"2022","unstructured":"Bailey CJ, Day C, Bellary S. Renal protection with SGLT2 inhibitors: effects in acute and chronic kidney disease. Curr Diab Rep. 2022;22:39\u201352. https:\/\/doi.org\/10.1007\/s11892-021-01442-z.","journal-title":"Curr Diab Rep"},{"key":"3157_CR9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.kint.2022.10.030","volume":"103","author":"S Rayego-Mateos","year":"2023","unstructured":"Rayego-Mateos S, Rodrigues-Diez RR, Fernandez-Fernandez B, Mora-Fern\u00e1ndez C, Marchant V, Donate-Correa J, et al. Targeting inflammation to treat diabetic kidney disease: the road to 2030. Kidney Int. 2023;103:282\u201396. https:\/\/doi.org\/10.1016\/j.kint.2022.10.030.","journal-title":"Kidney Int"},{"key":"3157_CR10","doi-asserted-by":"publisher","unstructured":"Libby P, Ridker PM, Hansson GK, Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54:2129\u201338. https:\/\/doi.org\/10.1016\/j.jacc.2009.09.009","DOI":"10.1016\/j.jacc.2009.09.009"},{"key":"3157_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.atherosclerosis.2018.07.014","volume":"276","author":"P Raggi","year":"2018","unstructured":"Raggi P, Genest J, Giles JT, Rayner KJ, Dwivedi G, Beanlands RS, et al. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Atherosclerosis. 2018;276:98\u2013108. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.07.014.","journal-title":"Atherosclerosis"},{"key":"3157_CR12","doi-asserted-by":"publisher","unstructured":"International Federation of Clinical Chemistry and Laboratory Medicine, IFCC Scientific Division, Mosca A, Goodall I, Hoshino T, Jeppsson JO, John WG, et al. Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group. Clin Chem Lab Med. 2007;45:1077\u201380. https:\/\/doi.org\/10.1515\/CCLM.2007.246","DOI":"10.1515\/CCLM.2007.246"},{"key":"3157_CR13","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385:1737\u201349. https:\/\/doi.org\/10.1056\/NEJMoa2102953.","journal-title":"N Engl J Med"},{"key":"3157_CR14","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2025. Diabetes Care. 2025;48:S239\u201351. https:\/\/doi.org\/10.2337\/dc25-S011","DOI":"10.2337\/dc25-S011"},{"key":"3157_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112189","volume":"224","author":"M Di Marco","year":"2025","unstructured":"Di Marco M, Scilletta S, Miano N, Capuccio S, Musmeci M, Di Mauro S, et al. Triglycerides to high density lipoprotein cholesterol ratio (TG\/HDL), but not triglycerides and glucose product (TyG) index, is associated with arterial stiffness in prediabetes. Diabetes Res Clin Pract. 2025;224:112189. https:\/\/doi.org\/10.1016\/j.diabres.2025.112189.","journal-title":"Diabetes Res Clin Pract"},{"key":"3157_CR16","doi-asserted-by":"publisher","unstructured":"Scilletta S, Di Marco M, Miano N, Capuccio S, Musmeci M, Bosco G, et al. Cardiovascular risk profile in subjects with diabetes: Is SCORE2-Diabetes reliable? Cardiovasc Diabetol [Internet]. Springer Science and Business Media LLC; 2025 [cited 2025 May 23];24. https:\/\/doi.org\/10.1186\/s12933-025-02769-7","DOI":"10.1186\/s12933-025-02769-7"},{"key":"3157_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/HJH.0b013e328365b29c","volume":"32","author":"F Viazzi","year":"2014","unstructured":"Viazzi F, Leoncini G, Derchi LE, Pontremoli R. Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient. J Hypertens. 2014;32:149\u201353. https:\/\/doi.org\/10.1097\/HJH.0b013e328365b29c.","journal-title":"J Hypertens"},{"key":"3157_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12933-016-0359-8","volume":"15","author":"AC Carlsson","year":"2016","unstructured":"Carlsson AC, \u00d6stgren CJ, Nystrom FH, L\u00e4nne T, Jennersj\u00f6 P, Larsson A, et al. Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in Type 2 diabetes. Cardiovasc Diabetol. 2016;15:40. https:\/\/doi.org\/10.1186\/s12933-016-0359-8.","journal-title":"Cardiovasc Diabetol"},{"key":"3157_CR19","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.jdiacomp.2016.03.015","volume":"30","author":"N G\u00f3mez-Banoy","year":"2016","unstructured":"G\u00f3mez-Banoy N, Cuevas V, Higuita A, Aranz\u00e1lez LH, Mockus I. Soluble tumor necrosis factor receptor 1 is associated with diminished estimated glomerular filtration rate in Colombian patients with Type 2 diabetes. J Diabetes Complic. 2016;30:852\u20137. https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.03.015.","journal-title":"J Diabetes Complic"},{"key":"3157_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jdiacomp.2017.09.007","volume":"32","author":"A Doody","year":"2018","unstructured":"Doody A, Jackson S, Elliott JA, Canavan RJ, Godson C, Slattery D, et al. Validating the association between plasma tumour necrosis factor receptor 1 levels and the presence of renal injury and functional decline in patients with Type 2 diabetes. J Diabetes Complic. 2018;32:95\u20139. https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.09.007.","journal-title":"J Diabetes Complic"},{"key":"3157_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119412","volume":"24","author":"A Scamporrino","year":"2023","unstructured":"Scamporrino A, Di Mauro S, Filippello A, Di Marco G, Di Pino A, Scicali R, et al. Identification of a new RNA and protein integrated biomarker panel associated with kidney function impairment in DKD: translational implications. Int J Mol Sci. 2023;24:9412. https:\/\/doi.org\/10.3390\/ijms24119412.","journal-title":"Int J Mol Sci"},{"key":"3157_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.diabres.2018.04.026","volume":"141","author":"T Gohda","year":"2018","unstructured":"Gohda T, Nishizaki Y, Murakoshi M, Nojiri S, Yanagisawa N, Shibata T, et al. Clinical predictive biomarkers for normoalbuminuric diabetic kidney disease. Diabetes Res Clin Pract. 2018;141:62\u20138. https:\/\/doi.org\/10.1016\/j.diabres.2018.04.026.","journal-title":"Diabetes Res Clin Pract"},{"key":"3157_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3195","volume":"35","author":"X Ye","year":"2019","unstructured":"Ye X, Luo T, Wang K, Wang Y, Yang S, Li Q, et al. Circulating TNF receptors 1 and 2 predict progression of diabetic kidney disease: a meta\u2010analysis. Diabetes Metab Res Rev. 2019;35:e3195. https:\/\/doi.org\/10.1002\/dmrr.3195.","journal-title":"Diabetes Metab Res Rev"},{"key":"3157_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070132","volume":"8","author":"T-W Hsu","year":"2013","unstructured":"Hsu T-W, Kuo K-L, Hung S-C, Huang P-H, Chen J-W, Tarng D-C. Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9 c\u00e2mara NOS, editor. PLoS ONE. 2013;8:e70132. https:\/\/doi.org\/10.1371\/journal.pone.0070132.","journal-title":"PLoS ONE"},{"key":"3157_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117725","volume":"553","author":"Y Fu","year":"2024","unstructured":"Fu Y, Song C, Qin Y, Zheng T, Zhou X, Zhao X, et al. Clinical value of serum MMP-3 in chronic kidney disease. Clin Chim Acta. 2024;553:117725. https:\/\/doi.org\/10.1016\/j.cca.2023.117725.","journal-title":"Clin Chim Acta"},{"key":"3157_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122212","volume":"10","author":"Y Sonoda","year":"2015","unstructured":"Sonoda Y, Gohda T, Suzuki Y, Omote K, Ishizaka M, Matsuoka J, et al. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy. PLoS ONE. 2015;10:e0122212. https:\/\/doi.org\/10.1371\/journal.pone.0122212.","journal-title":"PLoS ONE"},{"key":"3157_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/cells12182214","volume":"12","author":"A Arthanarisami","year":"2023","unstructured":"Arthanarisami A, Komaru Y, Katsouridi C, Schumacher J, Verges DK, Ning L, et al. Acute Kidney Injury-Induced circulating TNFR1\/2 elevations correlate with persistent kidney injury and progression to fibrosis. Cells. 2023;12:2214. https:\/\/doi.org\/10.3390\/cells12182214.","journal-title":"Cells"},{"key":"3157_CR28","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.2337\/dc12-2572","volume":"36","author":"EI Ekinci","year":"2013","unstructured":"Ekinci EI, Jerums G, Skene A, Crammer P, Power D, Cheong KY, et al. Renal structure in normoalbuminuric and albuminuric patients with Type 2 Diabetes and impaired renal function. Diabetes Care. 2013;36:3620\u20136. https:\/\/doi.org\/10.2337\/dc12-2572.","journal-title":"Diabetes Care"},{"key":"3157_CR29","doi-asserted-by":"publisher","DOI":"10.12703\/r\/11-21","author":"K Lee","year":"2023","unstructured":"Lee K, He JC. AKI-to-CKD transition is a potential mechanism for non-albuminuric diabetic kidney disease. Fac Rev. 2023. https:\/\/doi.org\/10.12703\/r\/11-21.","journal-title":"Fac Rev"},{"key":"3157_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/biom10010154","volume":"10","author":"M Provenzano","year":"2020","unstructured":"Provenzano M, Andreucci M, Garofalo C, Faga T, Michael A, Ielapi N, et al. The association of matrix metalloproteinases with chronic kidney disease and peripheral vascular disease: a light at the end of the tunnel? Biomolecules. 2020;10:154. https:\/\/doi.org\/10.3390\/biom10010154.","journal-title":"Biomolecules"},{"key":"3157_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-13-139","volume":"13","author":"N Big\u00e9","year":"2012","unstructured":"Big\u00e9 N, L\u00e9vy PP, Callard P, Faintuch J-M, Chigot V, Jousselin V, et al. Renal arterial resistive index is associated with severe histological changes and poor renal outcome during Chronic Kidney Disease. BMC Nephrol. 2012;13:139. https:\/\/doi.org\/10.1186\/1471-2369-13-139.","journal-title":"BMC Nephrol"},{"key":"3157_CR32","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s10157-015-1116-0","volume":"19","author":"N Kimura","year":"2015","unstructured":"Kimura N, Kimura H, Takahashi N, Hamada T, Maegawa H, Mori M, et al. Renal resistive index correlates with peritubular capillary loss and arteriosclerosis in biopsy tissues from patients with Chronic Kidney Disease. Clin Exp Nephrol. 2015;19:1114\u20139. https:\/\/doi.org\/10.1007\/s10157-015-1116-0.","journal-title":"Clin Exp Nephrol"},{"key":"3157_CR33","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1093\/hmg\/ddq172","volume":"19","author":"L Zhang","year":"2010","unstructured":"Zhang L, Connelly JJ, Peppel K, Brian L, Shah SH, Nelson S, et al. Aging-related atherosclerosis is exacerbated by arterial expression of tumor necrosis factor receptor-1: evidence from mouse models and human association studies. Hum Mol Genet. 2010;19:2754\u201366. https:\/\/doi.org\/10.1093\/hmg\/ddq172.","journal-title":"Hum Mol Genet"},{"key":"3157_CR34","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.008299","volume":"7","author":"AC Carlsson","year":"2018","unstructured":"Carlsson AC, Ruge T, Kj\u00f8ller E, Hilden J, Kolmos HJ, Sajadieh A, et al. 10-year associations between tumor necrosis factor receptors 1 and 2 and cardiovascular events in patients with Stable Coronary Heart Disease: a CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) trial substudy. J Am Heart Assoc. 2018;7:e008299. https:\/\/doi.org\/10.1161\/JAHA.117.008299.","journal-title":"J Am Heart Assoc"},{"key":"3157_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241213","volume":"15","author":"L Hassan","year":"2020","unstructured":"Hassan L, Medenwald D, Tiller D, Kluttig A, Ludwig-Kraus B, Kraus FB, et al. The association between change of soluble tumor necrosis factor receptor R1 (sTNF-R1) measurements and cardiovascular and all-cause mortality-results from the population-based (Cardiovascular Disease, Living and Ageing in Halle) CARLA study 2002-2016. PLoS ONE. 2020;15:e0241213. https:\/\/doi.org\/10.1371\/journal.pone.0241213.","journal-title":"PLoS ONE"},{"key":"3157_CR36","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1681\/ASN.2011060627","volume":"23","author":"MA Niewczas","year":"2012","unstructured":"Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, et al. Circulating TNF receptors 1 and 2 predict ESRD in Type 2 Diabetes. J Am Soc Nephrol. 2012;23:507\u201315. https:\/\/doi.org\/10.1681\/ASN.2011060627.","journal-title":"J Am Soc Nephrol"},{"key":"3157_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-015-0068-7","volume":"16","author":"BT Lee","year":"2015","unstructured":"Lee BT, Ahmed FA, Hamm LL, Teran FJ, Chen C-S, Liu Y, et al. Association of c-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with Chronic Kidney Disease. BMC Nephrol. 2015;16:77. https:\/\/doi.org\/10.1186\/s12882-015-0068-7.","journal-title":"BMC Nephrol"},{"key":"3157_CR38","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1159\/000335934","volume":"35","author":"M Pruijma","year":"2012","unstructured":"Pruijma M, Ponte B, Vollenweider P, Mooser V, Paccaud F, Waeber G, et al. Not all inflammatory markers are linked to kidney function: results from a population-based study. Am J Nephrol. 2012;35:288\u201394. https:\/\/doi.org\/10.1159\/000335934.","journal-title":"Am J Nephrol"},{"key":"3157_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02065-2","volume":"22","author":"M Di Marco","year":"2023","unstructured":"Di Marco M, Scilletta S, Miano N, Marrano N, Natalicchio A, Giorgino F, et al. Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease. Cardiovasc Diabetol. 2023;22:344. https:\/\/doi.org\/10.1186\/s12933-023-02065-2.","journal-title":"Cardiovasc Diabetol"},{"key":"3157_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02852-z","volume":"24","author":"O Janota-Sosi\u0144ska","year":"2025","unstructured":"Janota-Sosi\u0144ska O, Mantovani M, Irlik K, Kwiendacz H, Olejarz A, Pabis P, et al. Diabetic kidney disease phenotypes and the risk of cardiovascular events: The Silesia Diabetes-Heart Project. Cardiovasc Diabetol. 2025;24:305. https:\/\/doi.org\/10.1186\/s12933-025-02852-z.","journal-title":"Cardiovasc Diabetol"},{"key":"3157_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-024-04453-2","volume":"25","author":"S Wei","year":"2025","unstructured":"Wei S, Pan X, Xiao Y, Wei J. The unique association between estimated pulse wave velocity and the prevalence of diabetic kidney disease: a cross-sectional study. BMC Cardiovasc Disord. 2025;25:46. https:\/\/doi.org\/10.1186\/s12872-024-04453-2.","journal-title":"BMC Cardiovasc Disord"},{"key":"3157_CR42","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00125-017-4484-z","volume":"61","author":"CRL Cardoso","year":"2018","unstructured":"Cardoso CRL, Leite NC, Salles GC, Ferreira MT, Salles GF. Aortic stiffness and ambulatory blood pressure as predictors of diabetic kidney disease: a competing risks analysis from the Rio de Janeiro Type 2 Diabetes Cohort Study. Diabetologia. 2018;61:455\u201365. https:\/\/doi.org\/10.1007\/s00125-017-4484-z.","journal-title":"Diabetologia"},{"key":"3157_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11102870","volume":"11","author":"M Di Marco","year":"2022","unstructured":"Di Marco M, Urbano F, Filippello A, Di Mauro S, Scamporrino A, Miano N, et al. Increased platelet reactivity and proinflammatory profile are associated with intima-media thickness and arterial stiffness in prediabetes. J Clin Med. 2022;11:2870. https:\/\/doi.org\/10.3390\/jcm11102870.","journal-title":"J Clin Med"},{"key":"3157_CR44","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/17474124.2025.2471871","volume":"19","author":"A Giannakodimos","year":"2025","unstructured":"Giannakodimos A, Oikonomou E, Pantelidis P, Theofilis P, Katsiki N, Goliopoulou A, et al. Arterial stiffness as a complication of metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol. 2025;19:413\u201326. https:\/\/doi.org\/10.1080\/17474124.2025.2471871.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"3157_CR45","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1232583","volume":"2018","author":"K Batzias","year":"2018","unstructured":"Batzias K, Antonopoulos AS, Oikonomou E, Siasos G, Bletsa E, Stampouloglou PK, et al. Effects of newer antidiabetic drugs on endothelial function and arterial stiffness: a systematic review and meta-analysis. J Diabetes Res. 2018;2018:1232583. https:\/\/doi.org\/10.1155\/2018\/1232583.","journal-title":"J Diabetes Res"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03157-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03157-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03157-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T23:13:19Z","timestamp":1778454799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03157-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3157"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03157-5","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was in accordance with the Declaration of Helsinki and was approved by the local ethics committee (Comitato Etico Catania 2, protocol n. 270\/C.E. 26 April 2022). Informed consent was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}